SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand,

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

SK bioscience Appoints New Executives to Accelerate New Growth Strategies

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

CAMBRIDGE, England and SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology

CGTN: How China strengthens vaccine cooperation to battle COVID-19

AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S.

Another Step Forward in Global Expansion HONG KONG, Feb. 25, 2025 /PRNewswire/ -- As global capital

Dx&Vx, From mRNA Vaccines to Nanoparticle Vaccines era of Next-Generation Vaccines

Introduction of a Universal Coronavirus Vaccine : A robust cross-immunity effect to combat virus mutations.

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates